Donaldson acquires Isolere Bio

By Rachel Arthur

Donaldson Company will acquire Isolere Bio: an early-stage biotech that develops novel and proprietary ‘IsoTag’ reagents and accompanying filtration processes used for the purification and streamlined manufacturing of biopharmaceuticals.


Biotage acquires Astrea Bioseparations

By Rachel Arthur

Biotage will acquire Astrea Bioseparations, a chromatography solutions provider, from Gamma Biosciences: extending its chromatography franchise into the bioprocessing market for biologics and advanced therapeutic customers.


Flow Eighteen38 to double protein purification capacity

By Rachel Arthur

Flow Eighteen38, a protein sciences division created to facilitate and accelerate antibody characterization and protein purification projects, has announced a €5m ($5.58m) investment into its protein production and biophysical characterization capabilities...

© GettyImages/Shutter2U

Special Edition: The Future of Continuous BioProcessing

Addressing barriers to the shift to downstream continuous processing

By Nick Taylor

The shift away from batch downstream processing has moved closer in recent years amid progress on techniques such as antibody purification using continuous chromatography media. However, there remain barriers to clear before manufacturing facilities that...


Sartorius acquires BIA Separations for $423m

By Rachel Arthur

German life science company Sartorius will merge Slovenian purification specialist BIA Separations with Sartorius Stedim Biotech, in a deal worth €360m ($423m).

Roundup of the day’s top news at Interphex

Dispatches from Interphex

Roundup of the day’s top news at Interphex

By Zachary Brennan

The world’s top pharma and biologics manufacturing and processing companies have come together in New York this week to showcase the latest in equipment and services.

Repligen expands facilities in Massachusetts to meet customer demand

Repligen ups disposable chromatography column capacity

By Zachary Brennan

US biopharma company Repligen has completed a 9,000 square foot expansion of its facilities in Massachusetts to meet growing customer demand for disposable chromatography columns and warehousing.

Agilent splits up to create two separate businesses

Agilent splits up to create two separate businesses

Agilent Technologies has officially separated its biopharma service offerings from its electric measurement group to create two separate companies, the life science portion of which is expected to bring in about $3.9B in FY2013.

Biopharma Companies Look to New Chromatography Columns

Biopharma Companies Look to New Chromatography Columns

By Zachary Brennan

Biopharma firms, particularly those producing insulin and five of its analogues, have another option in the market of sub-2 micron solid-core chromatography columns with a recent offering from Waters.


Follow us


View more

Featured Suppliers